Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Naturally Occurring PCSK9 Inhibitors
Maria Pia Adorni, Francesca Zimetti, Maria Giovanna Lupo, et al.
Nutrients (2020) Vol. 12, Iss. 5, pp. 1440-1440
Open Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside
Xuhui Bao, Yongjun Liang, Hanman Chang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 59
A Patent Review on the Current Developments of Benzoxazoles in Drug Discovery
Xi Khai Wong, Keng Yoon Yeong
ChemMedChem (2021) Vol. 16, Iss. 21, pp. 3237-3262
Closed Access | Times Cited: 57
A comprehensive and systematic review on potential anticancer activities of eugenol: From pre-clinical evidence to molecular mechanisms of action
Syeda Nurunnesa Begum, Anindya Sundar Ray, Chowdhury Habibur Rahaman
Phytomedicine (2022) Vol. 107, pp. 154456-154456
Closed Access | Times Cited: 43
Development of small-molecule PCSK9 inhibitors for the treatment of hypercholesterolemia
Shakir Ahamad, Shintu Mathew, Waqas Ahmad Khan, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 5, pp. 1332-1349
Closed Access | Times Cited: 42
Anti-Inflammatory Effects of Lipid-Lowering Drugs and Supplements—A Narrative Review
Stefan Zivkovic, Gorica Marić, Nataša Cvetinovic, et al.
Nutrients (2023) Vol. 15, Iss. 6, pp. 1517-1517
Open Access | Times Cited: 30
A promising therapy for fatty liver disease: PCSK9 inhibitors
Lizhu Han, Liuyun Wu, Qinan Yin, et al.
Phytomedicine (2024) Vol. 128, pp. 155505-155505
Closed Access | Times Cited: 9
PCSK9: A Multi-Faceted Protein That Is Involved in Cardiovascular Biology
Sai Sahana Sundararaman, Yvonne Döring, Emiel P. C. van der Vorst
Biomedicines (2021) Vol. 9, Iss. 7, pp. 793-793
Open Access | Times Cited: 50
Recent Update on the Development of PCSK9 Inhibitors for Hypercholesterolemia Treatment
Shakir Ahamad, Shahnawaz Ali Bhat
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 23, pp. 15513-15539
Closed Access | Times Cited: 37
Protective alleles and precision healthcare in crewed spaceflight
Lindsay Rutter, Matthew MacKay, Henry Cope, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Emerging oral therapeutic strategies for inhibiting PCSK9
Nicola Ferri, Giorgia Marodin
Atherosclerosis Plus (2024) Vol. 59, pp. 25-31
Open Access | Times Cited: 6
Berberine: A Multi-Target Natural PCSK9 Inhibitor with the Potential to Treat Diabetes, Alzheimer’s, Cancer and Cardiovascular Disease
Caroline Coppinger, Briana Pomales, Mohammad Reza Movahed, et al.
Current Reviews in Clinical and Experimental Pharmacology (2024) Vol. 19, Iss. 4, pp. 312-326
Open Access | Times Cited: 5
Potential dual inhibitors of PCSK-9 and HMG-R from natural sources in cardiovascular risk management.
Mohd Waiz, Sahir Sultan Alvi, M. Salman Khan
PubMed (2022) Vol. 21, pp. 47-76
Closed Access | Times Cited: 21
Role of CETP, PCSK-9, and CYP7-alpha in cholesterol metabolism: Potential targets for natural products in managing hypercholesterolemia
Rita Ngozi Aguchem, Innocent Uzochukwu Okagu, Ekezie Matthew Okorigwe, et al.
Life Sciences (2024) Vol. 351, pp. 122823-122823
Open Access | Times Cited: 4
PCSK9 in metabolism and diseases
Amir Ajoolabady, Domenico Praticò, Mohsen Mazidi, et al.
Metabolism (2024) Vol. 163, pp. 156064-156064
Closed Access | Times Cited: 4
The Impacts of Cholesterol, Oxysterols, and Cholesterol Lowering Dietary Compounds on the Immune System
Rintaro Yanagisawa, Chaoqi He, Akira Asai, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12236-12236
Open Access | Times Cited: 17
Lowering LDL cholesterol by PCSK9 inhibition: a new era of gene silencing, RNA, and alternative therapies
Mitali Paryani, Nikita Gupta, Sanjay K. Jain, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Embelin Elevates Endoplasmic Reticulum Calcium Levels and Blocks the Sterol Regulatory Element‐Binding Protein 2 Mediated Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Improves the Low‐Density Lipoprotein Receptor Mediated Lipid Clearance on Hepatocytes
Mahesh Chandran, K. B. Rameshkumar, Abdul Jaleel, et al.
Chemical Biology & Drug Design (2025) Vol. 105, Iss. 2
Closed Access
Effects of PCSK9 inhibitors on cancer, diabetes, and cardiovascular diseases
Mojgan Nejabat, Farzin Hadizadeh, Wael Almahmeed, et al.
Drug Discovery Today (2025), pp. 104316-104316
Closed Access
Argan Fruit Polyphenols Regulate Lipid Homeostasis, Prevent Liver Fat Accumulation, and Improve Antioxidant Defense in High-Calorie Diet Fed Mice: In Vivo Study and In Silico Prediction of Possible Underlying Mechanisms
Mohammadine Moumou, Imane Mokhtari, Mohamed Harnafi, et al.
Metabolites (2025) Vol. 15, Iss. 4, pp. 234-234
Open Access
Kratom leaf extracts exert hypolipidaemic effects via the modulation of PCSK9 and LDLR pathways in HepG2 cells
Nantiya Nawaka, Monthon Lertcanawanichakul, Sureerut Porntadavity, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Cholesterol metabolism: A strategy for overcoming drug resistance in tumors
Jiahui Li, Yinping Guo, Wenjie Zhang, et al.
Biochemical Pharmacology (2025) Vol. 238, pp. 116974-116974
Closed Access
Regulatory effect of atorvastatin combined with berberine on PI3K/AKT/FoxO1 signaling pathway in rats with hyperlipidaemia
Chao Yu, Weihong Yin, Jiao Li, et al.
Xenobiotica (2025), pp. 1-8
Closed Access
Allicin and Capsaicin Ameliorated Hypercholesterolemia by Upregulating LDLR and Downregulating PCSK9 Expression in HepG2 Cells
Nantiya Nawaka, Smith Wanmasae, Arthit Makarasen, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14299-14299
Open Access | Times Cited: 16
Edible insect Locusta migratoria shows intestinal protein digestibility and improves plasma and hepatic lipid metabolism in male rats
Masaru Ochiai, Kou Tezuka, Haruka Yoshida, et al.
Food Chemistry (2022) Vol. 396, pp. 133701-133701
Closed Access | Times Cited: 14
TNFα-Induced LDL Cholesterol Accumulation Involve Elevated LDLR Cell Surface Levels and SR-B1 Downregulation in Human Arterial Endothelial Cells
Emmanuel U. Okoro
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6236-6236
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top